LON:GDR genedrive (GDR) Share Price, News & Analysis GBX 2.09 -0.04 (-1.88%) (As of 12:08 PM ET) Add Compare Share Share Today's Range 2.05▼ 2.1550-Day Range 1.72▼ 4.5152-Week Range 1.41▼ 13.50Volume3.33 million shsAverage Volume14.66 million shsMarket Capitalization£11.35 millionP/E RatioN/ADividend Yield1.57%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get genedrive alerts: Email Address Ad DTIFear of an impending recessionA lot of traders are worried about the threat of a recession… and with good reason. How can you guard against the worst case scenario? Use a tool that could see this collapse coming… Like my 10 AM Income Project. Back in July, the trading tool behind this 10 AM Income Project fired a serious warning signal… Even though NVDA was firing on all cylinders and every stock trader in the world seemed to want a piece, I saw the “red flag” because of these two lines…To discover how you could see the REAL crash BEFORE it starts, click here now. About genedrive Stock (LON:GDR)genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.Read More GDR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GDR Stock News HeadlinesAugust 16, 2024 | insidertrades.comgenedrive plc (LON:GDR) Insider Ian David Gilham Acquires 1,000,000 SharesSeptember 15 at 9:51 AM | finance.yahoo.comANGLE plc (DWV.F)September 16, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…September 14 at 6:51 AM | americanbankingnews.comgenedrive (LON:GDR) Share Price Passes Below Fifty Day Moving Average of $3.04August 9, 2024 | lse.co.ukTRADING UPDATES: FBD pretax profit falls; Getech's retail offerAugust 1, 2024 | lse.co.ukTurkiye Gdr Rgs Share ChatJuly 31, 2024 | lse.co.ukAIM WINNERS & LOSERS: Genedrive gets UK CYP2C19-ID test boostJuly 19, 2024 | msn.comGenedrive PLC: A 2024 Analysis and Future OutlookSeptember 16, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…May 15, 2024 | morningstar.comReliance Industries Ltd GDR - 144A RIGDMay 4, 2024 | morningstar.comReliance Industries Ltd GDR - 144AApril 26, 2024 | lse.co.ukGenedrive enters clinical trial deal in US for MT-RNR1 US approvalApril 19, 2024 | morningstar.comHindalco Industries Ltd GDRApril 5, 2024 | morningstar.comGenedrive PLC GDRMarch 23, 2024 | morningstar.comSUPCON Technology Co Ltd GDRMarch 17, 2024 | lse.co.ukReceipt of R&D tax creditMarch 9, 2024 | morningstar.comHindalco Industries Ltd GDR HNDNFFebruary 24, 2024 | morningstar.comITC Ltd GDR ITCSee More Headlines Receive GDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for genedrive and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/04/2020Today9/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:GDR Previous SymbolLON:EHP CUSIPN/A CIKN/A Webwww.genedriveplc.com Phone+44-161-9890245FaxN/AEmployees43Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.04) Trailing P/E RatioN/A Forward P/E Ratio0.01 P/E GrowthN/ANet Income£-5,000,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-201.53% Return on Assets-74.09% Debt Debt-to-Equity Ratio8.57 Current Ratio1.63 Quick Ratio5.52 Sales & Book Value Annual Sales£49,000.00 Price / Sales231.67 Cash FlowGBX 1.05 per share Price / Cash Flow2.00 Book ValueGBX 1 per share Price / Book2.09Miscellaneous Outstanding Shares543,140,000Free FloatN/AMarket Cap£11.35 million OptionableNot Optionable Beta-0.04 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Russell John Shaw (Age 46)CFO, Secretary & Director Comp: $158.08kMr. James Cheek (Age 57)CEO & Director Dr. Gino Miele (Age 54)Chief Scientific Officer & Executive Director Key CompetitorsANGLELON:AGLAbingdon HealthLON:ABDXYourgene HealthLON:YGENVerici DxLON:VRCIGENinCodeLON:GENIView All CompetitorsInsidersIan David GilhamBought 1,000,000 shares on 8/14/2024Total: £3 M ($3.00/share) GDR Stock Analysis - Frequently Asked Questions How have GDR shares performed this year? genedrive's stock was trading at GBX 8.13 at the beginning of the year. Since then, GDR shares have decreased by 74.3% and is now trading at GBX 2.09. View the best growth stocks for 2024 here. How were genedrive's earnings last quarter? genedrive plc (LON:GDR) released its quarterly earnings data on Tuesday, February, 4th. The company reported ($8.90) EPS for the quarter. How do I buy shares of genedrive? Shares of GDR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of genedrive own? Based on aggregate information from My MarketBeat watchlists, some other companies that genedrive investors own include NVIDIA (NVDA), Altria Group (MO), Netflix (NFLX), SolGold (SOLG), Tiziana Life Sciences (TILS), Asbury Automotive Group (ABG) and Allena Pharmaceuticals (ALNA). This page (LON:GDR) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding genedrive plc Please log in to your account or sign up in order to add this asset to your watchlist. Share genedrive With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
